Drug profile · INN
beclometasone + formoterol
FOSTAIR
beclometasone + formoterol (FOSTAIR) is a glucocorticoid receptor agonist. Associated with Cipla Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — beclometasone + formoterol
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
beclometasone + formoterol (FOSTAIR) is a glucocorticoid receptor agonist. Associated with Cipla Australia Pty Ltd.
Key facts
INN beclometasone + formoterol
Brand FOSTAIR
Mechanism Glucocorticoid receptor agonist
Target Glucocorticoid receptor
Originator Cipla Australia Pty Ltd
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is beclometasone + formoterol?
beclometasone + formoterol (FOSTAIR) is a glucocorticoid receptor agonist. Associated with Cipla Australia Pty Ltd.
What is the brand name for beclometasone + formoterol?
FOSTAIR is a marketed brand name for beclometasone + formoterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.